Two models for predicting the results of Gamma Knife surgery for brain stem and other centrally located arteriovenous malformations (AVMs) are presented. By using these models, the probability of total obliteration and the risk of complications can be predicted. The model to predict the probability for obliteration is based on the following two observations. First, there is a positive relationship between the minimum dose given to the AVM nidus and the incidence of obliteration. Second, there is a negative relationship between the AVM nidus volume and the minimum dose given in the obliterated cases. The risk estimation model is also based on two observations. First, centrally located AVMs carry a higher risk of complications than those located peripherally. Second, the average dose to volumes which are large for radiosurgery is related to the incidence of complications. The findings of this study may be used to estimate the consequences of Gamma Knife treatment for every individual case prior to the treatment. This makes a comparison between different treatment options and no treatment possible. The risk of hemorrhage without any treatment is also quantified.

Keywords:
Brain, Arteriovenous malformation, Risk, Gamma Knife, Radiosurgery
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.